Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
Chubb
Chinese Patent Office
US Department of Justice
Queensland Health
Dow
Fish and Richardson
Deloitte

Generated: July 19, 2018

DrugPatentWatch Database Preview

Emedastine difumarate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for emedastine difumarate and what is the scope of emedastine difumarate patent protection?

Emedastine difumarate
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for emedastine difumarate. One supplier is listed for this compound.
Pharmacology for emedastine difumarate
Synonyms for emedastine difumarate
(2Z)-but-2-enedioic acid; 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole
(E)-but-2-enedioic acid; 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
(E)-but-2-enedioic acid;1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
(Z)-but-2-enedioic acid; 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole
1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole
1-(2-Ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole bis[(2Z)-but-2-enedioate]
1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzo[d]imidazole difumarate
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole; fumaric acid
1-(2-Ethoxyethyl)-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
1-(2-ethoxyethyl)-2-(4-methylhexahydro-1h-1,4-diazepine-1-yl)-1h-benzimidazole
1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole
1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole fumarate (1:2)
1-(2-ethoxyethyl)-2-[(hexahydro-4-methyl-1h-1,4-diazepin)-1-yl]-1h-benzimidazole
1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole
1-Methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazo)-2-yl)(1,4)diazepane
1-methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepane
1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-
1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-, (E)-2-butenedioate (1:2)
1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-,(E)-2-butenedioate (1:2)
233E612
3B1-008670
42MB94QOSM
87233-61-2
87233-61-2 (Parent)
87233-62-3
87233-62-3 (difumarate)
9J1H7Y9OJV
AC-391
AC1L1FFW
AC1NR057
AC1O5P5D
AK117717
AKOS022185076
AL 3432A
AL-3432A
AN-15868
AN-35537
API0005026
BC226236
BDBM50019624
Benzimidazole, 1-(2-ethoxyethyl)-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)-, fumarate (1:2)
BRD-K15010214-313-01-6
C-23705
C07785
C17H26N4O
C17H26N4O.2C4H4O4
CAS-87233-62-3
CC-27452
CCG-220591
CHEBI:4779
CHEBI:59865
CHEMBL2103739
CHEMBL594
D02249
D02XJI
D07890
Daren
Daren (TN)
DB01084
DR002558
DSSTox_CID_26911
DSSTox_GSID_46911
DSSTox_RID_82009
DTXSID2046911
DTXSID7048243
E0936
Emadine
Emadine (TN)
Emedastina
Emedastina [INN-Spanish]
emedastine
Emedastine (INN)
Emedastine [INN:BAN]
Emedastine [INN]
Emedastine difumarate (JP17/USP)
Emedastine difumarate [USAN:USP:JAN]
Emedastine Difumarate [USAN]
emedastine difumarate ophthalmic solution
Emedastine fumarate
EMEDASTINE; BIS(FUMARIC ACID)
EMEDASTINE; MALEIC ACID
Emedastinum
Emedastinum [INN-Latin]
EX-A1371
FT-0693271
FT-0701236
GTPL7174
HE071277
HE399619
HE399620
K557
KB 2413
KB-2413
KB-50524
KBUZBQVCBVDWKX-UHFFFAOYSA-N
KG 2413
KG-2413
L001093
LS-177979
LS-32946
LY 188695
LY-188695
MolPort-006-167-701
NCGC00181341-01
NCGC00181341-02
Rapimine
Remicut
SC-94330
SCHEMBL1649085
SCHEMBL29770
SCHEMBL41384
SCHEMBL41385
SCHEMBL41386
SR-01000872706
SR-01000872706-1
Tox21_112800
Tox21_112800_1
UNII-42MB94QOSM
UNII-9J1H7Y9OJV
ZINC1530912

US Patents and Regulatory Information for emedastine difumarate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for emedastine difumarate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp EMADINE emedastine difumarate SOLUTION/DROPS;OPHTHALMIC 020706-001 Dec 29, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Deloitte
Farmers Insurance
Cerilliant
Chinese Patent Office
AstraZeneca
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.